首页> 外文会议>Photonic Therapeutics and Diagnostics II; Progress in Biomedical Optics and Imaging; vol.7, no.1 >Investigating the effects of combined photodynamic and anti-angiogenic therapies using a three-dimensional in-vivo brain tumor system
【24h】

Investigating the effects of combined photodynamic and anti-angiogenic therapies using a three-dimensional in-vivo brain tumor system

机译:使用三维体内脑肿瘤系统研究光动力疗法和抗血管生成疗法的联合治疗的效果

获取原文
获取原文并翻译 | 示例

摘要

An in-vivo tumor model composed of multicellular human glioma spheroids implanted on a shell-less chorioallantoic membrane (CAM), has been developed. Following removal of a portion of the ectodermal epithelium layer of the CAM, human glioma spheroids were implanted on day 7 of embryonic development. Tumor invasion, rapid growth and vasculature formation were observed 7 days post implantation. Single tumor cell migration towards blood vessels, angiogenesis and satellite tumor growth were also evident. The human tumor/CAM model is being used to examine the effects of combined ALA PDT and anti-angiogenic agents. The shell-less CAM is well suited for topical, i.p. and i.v. photosensitizer and/or drug application.
机译:已开发出一种由多细胞人神经胶质瘤球体植入无壳绒膜尿囊膜(CAM)组成的体内肿瘤模型。去除CAM的一部分表皮上皮层后,在胚胎发育的第7天植入人神经胶质瘤球体。植入后7天观察到肿瘤浸润,快速生长和脉管系统形成。单肿瘤细胞向血管迁移,血管生成和卫星肿瘤生长也很明显。人类肿瘤/ CAM模型正用于检查ALA PDT和抗血管生成剂联合治疗的效果。无壳CAM非常适合局部使用。和i.v.光敏剂和/或药物应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号